Table 1 Findings of the subgroup analysis for patient and graft survival

 1-Year

N = 1

87.5% (76–99)

N = 12

91.1% (87.2–95),

N = 35

92.1% (90.4–93.7)

N = 24

90.5% (87.9–93.1)

N = 4

86.2% (82.2–90.3)

 3-Year

N = 0

-

N = 8

80.7% (72.8–88.6)

N = 16

83.9% (80.1–87.8)

N = 7

82.1% (73.4–90.8)

N = 0

-

 5-Year

N = 0

-

N = 11

72.2% (64.8–79.5)

N = 30

80.8% (77.8–83.9)

N = 26

78.5% (75–82)

N = 4

73.3% (62.8–83.9)

 7-Year

N = 1

65.6% (49.2–82.1)

N = 1

58.7% (47.5–69.8)

N = 9

68.1% (59.7–76.6)

N = 0

-

N = 0

-

 10-Year

N = 0

-

N = 4

58.1% (41.7–74.5)

N = 16

64.3% (57.5–71.1)

N = 20

64.2% (58.9–69.5)

N = 0

-

 1-Year

N = 1

96.9% (90.8–1.00)

N = 11

99.9% (99.7–1.00)

N = 19

99.9% (99.7–1.00)

N = 16

97.1% (95.8–98.4)

N = 3

94.2% (91.3–97)

 3-Year

N = 0

-

N = 9

99.3% (98.5–1.00)

N = 8

89.3% (85.2–93.4)

N = 6

96.3% (92.7–99.8)

N = 0

-

 5-Year

N = 0

-

N = 12

97.5% (96.5–98.5)

N = 19

94.9% (93.8–96.1)

N = 19

93.9% (92.1–95.6)

N = 3

90.5% (83.5–97.5)

 7-Year

N = 1

84.4% (71.8–97.0)

N = 1

77.3% (67.9–86.8)

N = 2

70.3% (64.4–76.2)

N = 0

-

N = 0

-

 10-Year

N = 0

-

N = 6

88.8% (80.8–96.9)

N = 9

79.1% (71.2–87.0)

N = 15

91.9% (89.9–94.0)

N = 0

-